Axis Capital Holdings Limited (AXS) Stock Price & How to Invest

AXIS Capital Holdings is a global specialty underwriter operating through two platforms: AXIS Insurance, which writes specialty lines such as property, marine, cyber, professional lines, and U.S. excess and surplus, and AXIS Re, which provides specialty reinsurance. The company is incorporated in Bermuda with operations across the U.S., Europe, Singapore, and Canada, and in recent years has leaned into higher-margin specialty insurance while cycle-managing its reinsurance exposure toward more attractive lines.

The investment picture centers on underwriting discipline and capital returns. AXS entered 2026 with roughly 11% growth in gross premiums written and a combined ratio below 90%, meaning it earned an underwriting profit before investment income. Trailing twelve-month revenue reached about $6.8 billion by mid-2026, up about 7% year over year, with net income near $1.07 billion. Earnings are inherently lumpy because catastrophe losses can swing results in any given quarter, and Q2 2026 showed it: EPS of $2.84 came in below the roughly $3.24 consensus. The stock tends to be valued on price-to-book and normalized returns on equity rather than smooth revenue growth, and it pairs a single-digit earnings multiple (about 7x trailing and 7.4x forward) with a dividend yielding about 1.8% and ongoing buybacks.

As of 2026-10-16 the shares closed near $99, within a 52-week range of about $88 to $120. They are down about 5% year to date and up about 7.5% over the past year. Analysts covering the stock carry an average price target near $120 and a consensus buy rating, though BofA trimmed its target to $121 from $131 in October while keeping a neutral view.

Catastrophe exposure is the primary risk: a severe hurricane, wildfire, or other large-loss event can turn a profitable quarter into a loss, and reinsurance amplifies this volatility. The Q2 2026 EPS miss shows how quickly results can come in below expectations, and consensus now looks for full-year 2026 EPS of about $12.25, roughly 5% lower than 2025. Reserve development is another risk, since claims for long-tail casualty lines can prove more costly than originally estimated years later. The business is also cyclical, so softening insurance pricing (a soft market) would compress margins across specialty lines. Investment results depend on credit and interest-rate conditions, and as a Bermuda-domiciled global insurer AXS is exposed to regulatory and tax changes across multiple jurisdictions.

11 analysts publish price targets on AXS, averaging $119.55 against a $99.63 price as of October 2026, or +20.0%. The published targets run from $104.00 to $130.00, a narrow spread, and the ratings split 8 buy, 4 hold, 0 sell. Over the last six months there have been 4 raises and 7 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full AXS forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Axis Capital Holdings Limited. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Specialty insurance growth. AXIS has been expanding its Insurance segment faster than peers, with roughly 20% growth reported in early 2026 across specialty lines including U.S. The most optimistic published target, $130.00, assumes this works close to its best case.

The case against. Catastrophe exposure is the primary risk: a severe hurricane, wildfire, or other large-loss event can turn a profitable quarter into a loss, and reinsurance amplifies this volatility. The most pessimistic target, $104.00, is roughly what AXS is worth if this bites instead.

Read the full bull and bear case on AXS, including what would have to change to break either one. Walnut is not an investment adviser.

No. Axis Capital Holdings Limited (AXS) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Axis Capital Holdings Limited's investor relations page or your broker.

• Market cap: ~$7.3B
• Revenue (TTM): ~$6.8B (+7% YoY)
• Net income (TTM): ~$1.07B (~16% margin)
• EPS (TTM): ~$14.06
• P/E (TTM / forward): ~7.0x / ~7.4x
• Price / book: ~1.2x
• Dividend yield: ~1.8%

AXS trades at about 7 times trailing earnings and around 1.2 times book value, valuation levels typical of profitable but cyclical specialty insurers rather than growth stocks. The forward P/E sits slightly above the trailing figure because analysts expect 2026 EPS to dip about 5% before recovering about 9% in 2027. Q2 2026 EPS of $2.84 missed estimates, and the Q3 report is scheduled for October 28, 2026, with consensus EPS near $2.85.

Other names that sit close to AXS: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get AXS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so AXS sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where AXS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

AXS is a mid-cap specialty insurance and reinsurance name whose case rests on sustained underwriting profit and steady book-value compounding rather than rapid growth. A Q2 2026 earnings miss has pulled the shares about 13% lower over three months, and the Q3 report on October 28, 2026 is the next test.

Whether AXS is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is AXS a buy or a sell?, and where the stock could go from here in the AXS stock forecast.

For income investors, whether AXS pays a dividend and how the payout looks is covered in does AXS pay a dividend? And to weigh AXS against a peer, read the full side-by-side comparisons: AXS vs RNR and AXS vs EG.